Select language:

Russia applied to register COVID-19 vaccine in Europe

 / Главная / Russkiy Mir Foundation / News / Russia applied to register COVID-19 vaccine in Europe

Russia applied to register COVID-19 vaccine in Europe


25.11.2020

Photo credit: the press service of the Russian Ministry of Health

The production site of the Russian Sputnik V vaccine may appear in Germany, RIA Novosti reports. According to Kirill Dmitriev, who heads the Russian Direct Investment Fund (RDIF), negotiations on production are underway with many European countries.

The foundation has sent an application for approval of the drug by the European Medical Association, said Kirill Dmitriev. In the coming days, RDIF will receive a large French delegation, he added, and promised that work with the European Union would continue.

The first samples of Sputnik V vaccine were brought to Hungary. It became the first country in Europe to aquire the Russian vaccine. Earlier it became known that the drug was planned to be produced in Hungary, where they were already working on the preparation of the production site.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.